0000899243-20-002868.txt : 20200204 0000899243-20-002868.hdr.sgml : 20200204 20200204180204 ACCESSION NUMBER: 0000899243-20-002868 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200131 FILED AS OF DATE: 20200204 DATE AS OF CHANGE: 20200204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sorensen Mel CENTRAL INDEX KEY: 0001444783 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39114 FILM NUMBER: 20575292 MAIL ADDRESS: STREET 1: 7 RAPPS RUN DRIVE CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Galera Therapeutics, Inc. CENTRAL INDEX KEY: 0001563577 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461454898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 WEST LIBERTY BLVD #100 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-725-1500 MAIL ADDRESS: STREET 1: 2 WEST LIBERTY BLVD #100 CITY: MALVERN STATE: PA ZIP: 19355 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-31 0 0001563577 Galera Therapeutics, Inc. GRTX 0001444783 Sorensen Mel C/O GALERA THERAPEUTICS, INC., 2 W LIBERTY BLVD #100 MALVERN PA 19355 1 1 0 0 President and CEO Stock Option (Right to Buy) 14.84 2020-01-31 4 A 0 186087 0.00 A 2030-01-30 Common Stock 186087 186087 D The option vests and becomes exercisable in equal monthly installments over a four year period commencing January 31, 2020. /s/ J. Mel Sorensen 2020-02-04